Poging GOUD - Vrij

Bio Spectrum - December 2018

Ga onbeperkt met Magzter GOLD

Lezen Bio Spectrum samen met 9000+ andere tijdschriften en kranten met slechts één abonnement

Bekijk catalogus

1 maand

$14.99

1 jaar $149.99

$149.99

$12/month

(OR)

Abonneer u alleen op Bio Spectrum

Geschenk Bio Spectrum

Op elk gewenst moment opzegbaar.

(Geen verplichtingen) ⓘ

Als u niet tevreden bent met uw abonnement, kunt u binnen 7 dagen na de ingangsdatum van het abonnement een e-mail sturen naar help@magzter.com voor een volledige terugbetaling. Geen vragen gesteld - beloofd! (Let op: niet van toepassing op losse nummers)

Digitaal abonnement

Directe toegang ⓘ

Abonneer je nu en begin direct met lezen via de Magzter website, iOS, Android en Amazon apps.

Geverifieerd beveiligd

betaling ⓘ

Magzter is een geverifieerde Stripe-handelaar.

In dit nummer

2018: INDUSTRY RE-STRATEGISES BUSINESS PLANS
COVER
DESIGN BY:
DOMINIX STRATEGIC DESIGN PVT. LTD.
India is increasingly gaining the much-needed Government focus on expanding affordable health care. This year, India took a giant leap towards providing accessible and affordable healthcare to the common man with the launch of Ayushman Bharat in September, 2018. In parallel, the Government remains committed to establishing India as a global manufacturing hub for medical devices with this sector expected to increase significantly. The new medical device rules which came into force from January 2018 has finally given the medical devices and in-vitro diagnostic devices (IVD) industry a distinctive regulatory identity. Scientific development in India is definitely contributing immensely to improved healthcare, improved devices, diagnostics and much more. Hence companies are re-strategising their business plans appropriately to make difference to the consumers.

Bio Spectrum Description:

Uitgever: MM-Activ-Sci-Tech-Communication

Categorie: Business

Taal: English

Frequentie: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.